Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

The management of patients with chronic myeloid leukemia (CML) has been revolutionized by the introduction of tyrosine kinase inhibitors (TKIs), which induce deep molecular responses so that treatment can eventually be discontinued, leading to treatment-free remission (TFR) in a subset of patients....

Full description

Bibliographic Details
Main Authors: Henrike Jacobi, Margherita Vieri, Marlena Bütow, Carolina Y. Namasu, Laura Flüter, Ivan G. Costa, Tiago Maié, Katharina Lindemann-Docter, Nicolas Chatain, Fabian Beier, Michael Huber, Wolfgang Wagner, Martina Crysandt, Tim H. Brümmendorf, Mirle Schemionek
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Pharmacology
Subjects:
CML
TFR
fibrosis
leukemic stem cells
LSC
MSc
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1212392/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1212392/full

Similar Items